FTSE Reshuffle: Abrdn, Hikma and Howden to exit FTSE 100
What is the FTSE reshuffle?
The FTSE 100 represents the 100 most-valuable publicly-listed companies in the UK, while the FTSE 250 is made up of the next 250 largest companies. Both of these indices are reviewed once every quarter by provider FTSE Russell, which calculates the valuations of UK companies to decide which stocks should be in which index. This sees some companies relegated and others promoted from their indices.
Read more: What is the stock market and how does it work?
When is the FTSE index review?
The latest reshuffle is set to become effective when UK stock markets open on Monday September 19. However, as UK stock markets will be closed for the Queen’s funeral, this looks set to take place when they reopen on Tuesday September 20.
Importantly, relegations and promotions are based on market capitalisations of each individual company at the end of play on August 30.
Read more: What is market capitalisation and is it a good measure of success?
How does the FTSE reshuffle work?
In order to join the FTSE 100, a company must have a market cap that would place it in the top 90 largest stocks on the UK stock market. Any existing member of the FTSE 100 that sees its valuation fall below the top 110 companies in the stock market is booted-out and relegated to the FTSE 250.
That means the FTSE 250 has additions made at both ends. The most valuable firms in the index are promoted to the FTSE 100 and replaced by those that are relegated from the FTSE 100. Meanwhile, the least valuable firms are booted out of the index altogether and replaced by new entrants. Any company that sees its value fall below the top 375 UK companies is ousted from the FTSE 250 and joins the FTSE SmallCap index, while any companies that boast a value in the top 325 stocks join the FTSE 250.
FTSE 100 reshuffle
Exiting FTSE 100 |
Entering FTSE 100 |
Abrdn |
ConvaTec Group |
Hikma Pharmaceuticals |
F&C Investment Trust |
Howden Joinery Group |
Harbour Energy |
FTSE 100 relegations
Abrdn, which rebranded itself last year from Standard Life Aberdeen, will lose its blue-chip status after falling over 42% in 2022, significantly underperforming the wider market. Asset management has been hit hard by the selloff this year, and Abrdn continues to report large outflows of cash while efforts to lower costs are taking longer than anticipated.
Hikma Pharmaceuticals is down 43% since the start of the year as profits have fallen due to tough comparatives and weaker pricing for its generic drugs, which prompted it to cut its full year outlook in August.
Howden Joinery Group’s life as a blue-chip stock was short-lived considering it only joined the FTSE 100 earlier this year. The kitchen supplier and DIY outlet was propelled into the big leagues after business boomed during the pandemic. It has kept up the momentum considering sales and profits have continued to grow and remain well-above pre-pandemic levels this year, but that has not stopped it being caught-up in the selloff as fears about a pullback in discretionary spending grow.
FTSE 100 promotions
ConvaTec Group shares are up over 16% in 2022, an impressive performance considering the FTSE 250 lost over one-fifth in value. The company, which makes medical devices such as catheters, has been pivoting toward sustainable and profitable growth this year and has said it is aiming to grow faster than its peers. It decided to withdraw from non-core hospital activities in May and then entered the faster-growing biologics market by purchasing Triad Life Sciences to strengthen its position in the advanced wound care market in the US.
F&C Investment Trust shares have lost ground this year after suffering from depressed equity markets, but it has suffered a milder decline than the wider market and rallied over 20% during the two months to mid-August, enough to push it into the FTSE 100. The company has a diverse investment portfolio mostly angled toward the US. Its private equity investments have helped counter the drop in public markets and it has signalled that dividends will continue to grow going forward.
Shares in Harbour Energy, which was created by the merger of Chrysaor and Premier Oil in 2021, have popped by over 64% since hitting 30-month lows in early July and are worth over one-third more than at the start of 2022. The oil and gas company has reaped rewards from higher prices, enough for it to pay its maiden dividend and launch a share buyback. Plans to be debt free in 2023 also paints a rosy picture for future returns. Its ability to continue cutting production costs this year, even amid the inflationary environment, has allowed it to capitalise on the rise in energy prices, even if its hedging programme continues to be a hindrance in the current environment.
FTSE 250 reshuffle
Exiting FTSE 250 |
Entering FTSE 250 |
ConvaTec Group |
Abrdn |
F&C Investment Trust |
Hikma Pharmaceuticals |
Harbour Energy |
Howden Joinery Group |
Chrysalis Investments |
Bluefield Solar Income Fund |
Greencore Group |
NextEnergy Solar Fund |
Provident Financial |
PureTech Health |
Tyman |
Twentyfour Income Fund |
XP Power |
Warehouse REIT |
FTSE 250 relegations
Chrysalis Investments has plunged over 73% in 2022 and currently trades at all-time lows. The company, which invests in UK and European private companies and counts the likes of buy-now, pay-later outfit Klarna, Starling Bank and payments firm Wise on its books, has seen its net asset value take a hit this year as fears around inflation and rising interest rates has hurt the value of its holdings.
Greencore Group shares are down over 35% in 2022 and hit levels not seen since 2013. The convenience food maker has seen sales continue to rise this year thanks to both higher volumes and prices, although inflation threatens the outlook and it has warned it will remain a challenge into 2023. It plans to recover any lost profitability from inflation going forward and is on course to post a significant jump in earnings this year.
It has been an extremely tough few years for Provident Financial, which closed its doorstep lending business after 141 years in 2021 and transformed itself into a ‘specialist banking group’. The company has fallen from grace since joining the FTSE 100 back in 2015 before falling into the FTSE 250 in 2017. Shares have halved this year and linger near two-year lows.
Tyman will exit the FTSE 250 after losing almost half of its value this year with shares trading at two-year lows. The company, which makes components for windows and doors like handles and locks, has grown sales, profits and dividends this year but growth is slowing at a time when the housing market appears to be cooling down, placing pressure on the outlook with profits forecast to decline in 2022 following the double-digit rise seen in 2021.
XP Power, which makes critical power systems, has fallen 64% this year and hit levels last seen in 2017. The company has been caught up in the selloff of tech and semiconductor stocks and has suffered from component shortages, supply chain problems and Covid-19 disruption in China. Demand has remained strong, but it is facing a tough time delivering and has taken a cautious view to its outlook, warning it could miss expectations because of the limited visibility available.
FTSE 250 promotions
The FTSE 250 will welcome two renewable funds during this reshuffle, with Bluefield Solar Income Fund and NextEnergy Solar Fund both rising to multi-year highs in 2022 as the spike in energy prices has lifted their net asset values this year.
TwentyFour Income Fund invests in less-liquid but higher-yielding asset-backed securities in Europe. The fund has fallen around 9% this year but has still outperformed the market, with sentiment rising as its portfolio will benefit from rising interest rates.
Warehouse REIT has also outperformed the market despite finding itself in negative territory this year, although it rallied during the rebalance period in the third quarter. The last-mile warehouse investor has grown the value of its portfolio to over £1 billion in less than five years.
Biotech firm PureTech Health, which makes medicines for serious diseases, has rallied over 68% since hitting four-year lows in the middle of June and will join the FTSE 250 after listing back in 2015. It delivered ‘stellar’ results from a trial of a new schizophrenia drug and it hopes to replicate the success here by applying its methods to discovering new drugs for other ailments. After all, it claims its clinical research is ‘six times better than the biopharma average’.
Why is the FTSE reshuffle important?
Stocks that are moving down the list of the UK’s top 350 most-valuable companies are, for one reason or another, falling out of favour and underperforming while those moving up the ranks are typically gaining momentum and outperforming the wider market.
A study by Smith’s Corporate Advisory suggests a stock that is bumped-up into the FTSE 100 rises around 15% on average in the two months leading up to the day of the reshuffle and go on to add another 2% between the move being confirmed and it becoming effective. Interestingly, they fall by around 5% on average in the two months after joining the index.
At the other end, those that fall out of the FTSE 100 drop by an average of around 19% in the two months leading up to the reshuffle and also gain 2% by the time it becomes effective, while staying broadly flat in the subsequent two months.
The reshuffle also dictates what funds a stock is included in. For example, a passive fund that tracks the FTSE 100 will no longer invest in a stock that is relegated into the FTSE 250. This means that many funds will rejig their portfolios to take the latest movements into account, which in turn can influence how the impacted stocks perform.
Read more: How to trade the FTSE 100
Reputation is also at stake. Stocks in the FTSE 100 are known as ‘blue-chip’ stocks, which are the biggest companies generally regarded as among the most financially secure and highest quality businesses. Meanwhile, those in the FTSE 250 are known as ‘mid-cap’ stocks that have medium-sized valuations. This means it can impact how each individual stock is viewed by the market.
When is the next FTSE reshuffle?
The next FTSE reshuffle will take effect when UK markets open on Monday December 19, based on valuations when markets close on Tuesday November 29.
How to trade UK stocks
You can trade a variety of UK shares with Forex.com in just four steps:
- Open a Forex.com account, or log-in if you’re already a customer.
- Search for the stock you want in our award-winning platform
- Choose your position and size, and your stop and limit levels
- Place the trade
Or you can try out your trading strategy risk-free by signing up for our Demo Account.
The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex, commodity futures, or digital assets, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to FOREX.com or GAIN Capital refer to StoneX Group Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.
The products and services available to you at FOREX.com will depend on your location and on which of its regulated entities holds your account.
FOREX.com is a trading name of GAIN Global Markets Inc. which is authorized and regulated by the Cayman Islands Monetary Authority under the Securities Investment Business Law of the Cayman Islands (as revised) with License number 25033.
FOREX.com may, from time to time, offer payment processing services with respect to card deposits through StoneX Financial Ltd, Moor House First Floor, 120 London Wall, London, EC2Y 5ET.
GAIN Global Markets Inc. has its principal place of business at 30 Independence Blvd, Suite 300 (3rd floor), Warren, NJ 07059, USA., and is a wholly-owned subsidiary of StoneX Group Inc.
© FOREX.COM 2024